Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Sep;63(9):1009-1013.
doi: 10.1038/s10038-018-0477-0. Epub 2018 Jun 18.

Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment

Affiliations
Clinical Trial

Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment

Kishin Koh et al. J Hum Genet. 2018 Sep.

Abstract

Hereditary spastic paraplegias (HSPs) are characterized by various inherited disorders in which weakness and spasticity of the lower extremities are the predominant symptoms. Recently, HSP caused by ALDH18A1 mutations has been reported as SPG9 with autosomal dominant (SPG9A) and autosomal recessive (SPG9B) transmission. In this study, we obtained clinical and genetic findings in two Japanese families with SPG9B. One family had a novel compound heterozygous mutation (c.1321 C > T/c.1994G > A) in the ALDH18A1 gene. The other family had a homozygous mutation (c.383 G > A/c.383 G > A) in the ALDH18A1 gene. To date, only two SPG9B families with ALDH18A1 mutations have been reported. This is the first report of SPG9 in non-Caucasians. Furthermore, we found cerebellar ataxia in one family, although cerebellar ataxia has not been reported in SPG9B so far. SPG9B might involve a complicated HSP including cerebellar ataxia and cognitive impairment. This study expands the clinical and genetic spectrum of ALDH18A1-related disorders.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mol Genet Metab. 2014 Aug;112(4):310-6 - PubMed
    1. Nat Commun. 2017 Jun 12;8:15824 - PubMed
    1. Lancet Neurol. 2008 Dec;7(12):1127-38 - PubMed
    1. Eur J Hum Genet. 2008 Oct;16(10):1176-86 - PubMed
    1. Hum Mol Genet. 2012 Jun 1;21(11):2497-502 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources